A precise and sustainable doxycycline-inducible cell line development platform for reliable mammalian cell engineering with gain-of-function mutations

Conference Dates

April 27 - May 2, 2025

Abstract

Please click Additional Files below to see the full abstract

150.pdf (74 kB)

This document is currently not available here.

Share

COinS